Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.90
+0.05 (0.85%)
Oct 19, 2026, 12:42 PM EDT - Market open
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $288.45 million as of October 19, 2026. It is the 18,542nd most valuable company in the world and the 3,228th biggest in the United States. Its market cap has increased by 96.49% in one year.
Market Cap
288.45M
Enterprise Value
-51.09M
1-Year Change
96.49%
Global Rank
Country Rank
#3,228 United States
Category
ChartMarket Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $288.45M, an increase of 63.19%. That is a compound annual growth rate of 24.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 288.45M | 173.94% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 314.86M |
| Inhibikase Therapeutics | 300.42M |
| Arcturus Therapeutics Holdings | 293.89M |
| Benitec Biopharma | 282.90M |
| Fulcrum Therapeutics | 278.48M |
| Surrozen | 275.50M |
| Agenus | 271.92M |
| Contineum Therapeutics | 266.36M |